We are comparing different treatment plans for newly diagnosed chronic lymphocytic leukemia patients to see if a personalized approach improves outcomes. This includes assessing how long patients can stay in remission and the overall effectiveness of the treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
Chronic Lymphocytic Leukaemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to an overproduction of abnormal lymphocytes, which can cause symptoms like fatigue, swollen lymph nodes, and frequent infections.
Small Lymphocytic Lymphoma (SLL) is a type of non-Hodgkin lymphoma that primarily affects the lymph nodes and is characterized by the accumulation of small, abnormal lymphocytes, leading to symptoms such as swollen lymph nodes and fatigue.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
